Advertisement
The new study, Cell-Based Diagnostics: Technologies, Applications, andMarkets, 2nd Edition, evaluates the market for both traditional technologiessuch as hematology, flow cytometry, and traditional stains, as well asincreasingly sophisticated molecular techniques and the emerging areas of rarecell event testing, microarrays and beadarrays. These new technologies anddigital arrays carry the advantage of being well suited to feed data tosoftware designed to interpret array patterns and create the test result.
Advertisement
These innovations and new methods for genotyping biopsied tissue couldrevolutionize the treatment of a number of diseases, including: diabetes,cancer, and autoimmune and neurodegenerative diseases and could lead the wayto an era of individualized patient therapies using techniques such asmicroarrays, biochips, PCR and in situ hybridization.
"The potential for these technologies is huge," notes Shara Rosen, analystfor Kalorama Information and the author of the study. "In fact, while ourcurrent market evaluations are based on commercialized assays and reagents,there is also a vast menu of in-lab developed, or 'home-brew' tests usingtissue stains, flow reagents, antibodies, molecular probes and dyes marketedby scores of companies, worldwide. As the science of cell diagnostics isperfected, many of these tests are going main stream as authorized testservices or market cleared tests."
Kalorama Information's 2nd Edition of Cell-Based Diagnostics: Technology,Application and Markets, reviews technologies available and in developmentfrom nearly 200 companies and discusses the impact of cell-based diagnosticson patient care, as well as in drug discovery and development research.Analysis of market trends and market forecasts for twelve cell diagnosticsegments are also provided. The report can be purchased directly from KaloramaInformation by visitinghttp://www.kaloramainformation.com/Cell-Based-Diagnostics-1393079/, and isalso available at www.MarketResearch.com.
About Kalorama Information
Kalorama Information supplies the latest in independent market research onmedical markets. For more information, contact Tom Ehart at 240-747-3014 [email protected], or visit www.KaloramaInformation.com.
SOURCE Kalorama Information
